|
KIF3A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.524200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.634800E-01 |
| Normal-vs-Stage2 |
2.746200E-01 |
| Normal-vs-Stage3 |
5.906400E-01 |
| Normal-vs-Stage4 |
6.557000E-01 |
| Stage1-vs-Stage2 |
6.164800E-01 |
| Stage1-vs-Stage3 |
6.142800E-01 |
| Stage1-vs-Stage4 |
6.689200E-01 |
| Stage2-vs-Stage3 |
4.526000E-01 |
| Stage2-vs-Stage4 |
4.573200E-01 |
| Stage3-vs-Stage4 |
9.691800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.434600E-01 |
| Normal-vs-AfricanAmerican |
7.794000E-02 |
| Normal-vs-Asian |
3.279600E-01 |
| Caucasian-vs-AfricanAmerican |
2.720800E-01 |
| Caucasian-vs-Asian |
7.469200E-01 |
| AfricanAmerican-vs-Asian |
4.225400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.947800E-01 |
| Normal-vs-Female |
1.341440E-01 |
| Male-vs-Female |
7.597900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.655600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.068000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.220600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.962200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.280800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.055000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.419600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.716000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.044830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.132200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.324100E-02 |
| Classical-VS-Follicular |
2.196100E-02 |
| Classical-VS-Other |
5.941800E-01 |
| Classical-VS-Normal |
4.094300E-02 |
| Tall-VS-Follicular |
7.688600E-01 |
| Tall-VS-Other |
6.651600E-01 |
| Tall-VS-Normal |
6.440600E-01 |
| Follicular-VS-Other |
8.255400E-01 |
| Follicular-VS-Normal |
8.548800E-01 |
| Other-VS-Normal |
8.499200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.660800E-01 |
| Normal-vs-N1 |
5.427200E-01 |
| N0-vs-N1 |
7.785200E-01 |
|
|
